Archived: Breast Cancer: Medications for Risk Reduction
Original Release Date: September 2013
This version of this topic is currently archived and inactive. It should be used for historical purposes only.
Archived: Recommendation Summary
|Women, Increased Risk for Breast Cancer|
The USPSTF recommends that clinicians engage in shared, informed decision making with women who are at increased risk for breast cancer about medications to reduce their risk. For women who are at increased risk for breast cancer and at low risk for adverse medication effects, clinicians should offer to prescribe risk-reducing medications, such as tamoxifen or raloxifene.
|Women, Not at Increased Risk for Breast Cancer|
The USPSTF recommends against the routine use of medications, such as tamoxifen or raloxifene, for risk reduction of primary breast cancer in women who are not at increased risk for breast cancer.
Go to the Clinical Considerations for additional information about risk factors.
Archived: Related Information for Consumers
Internet Citation: Final Update Summary: Breast Cancer: Medications for Risk Reduction. U.S. Preventive Services Task Force. September 2016.